These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 19668980

  • 21. Indocyanine green angiography-guided management of Vogt-Koyanagi-Harada disease: differentiation between choroidal scars and active lesions.
    Knecht PB, Mantovani A, Herbort CP.
    Int Ophthalmol; 2013 Oct; 33(5):571-7. PubMed ID: 23277207
    [Abstract] [Full Text] [Related]

  • 22. Vogt-Koyanagi-Harada disease: recurrence rates after initial-onset disease differ according to treatment modality and geographic area.
    Herbort CP, Tugal-Tutkun I, Khairallah M, Abu El Asrar AM, Pavésio CE, Soheilian M.
    Int Ophthalmol; 2020 Sep; 40(9):2423-2433. PubMed ID: 32418076
    [Abstract] [Full Text] [Related]

  • 23. Polarization-Sensitive Optical Coherence Tomographic Documentation of Choroidal Melanin Loss in Chronic Vogt-Koyanagi-Harada Disease.
    Miura M, Makita S, Yasuno Y, Tsukahara R, Usui Y, Rao NA, Ikuno Y, Uematsu S, Agawa T, Iwasaki T, Goto H.
    Invest Ophthalmol Vis Sci; 2017 Sep 01; 58(11):4467-4476. PubMed ID: 28863408
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Vitiligo revealing Vogt -Koyanagi-Harada disease].
    Amraoui ME, Zemmez Y, Bouhamidi A, Frikh R, Hjira N, Boui M.
    Pan Afr Med J; 2017 Sep 01; 27():220. PubMed ID: 28979622
    [Abstract] [Full Text] [Related]

  • 28. A COVID-19 perspective of Vogt-Koyanagi-Harada disease.
    Dutta Majumder P, Sadhu S, González-López JJ, Mochizuki M.
    Indian J Ophthalmol; 2023 Jun 01; 71(6):2587-2591. PubMed ID: 37322685
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Vogt-Koyanagi-Harada disease after head trauma.
    Accorinti M, Pirraglia MP, Corsi C, Caggiano C.
    Eur J Ophthalmol; 2007 Jun 01; 17(5):847-52. PubMed ID: 17932867
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Vogt-Koyanagi-Harada syndrome in children].
    Laghmari M, Karim A, Ibrahimy W, Essakalli NH, Mohcine Z.
    J Fr Ophtalmol; 2002 Jun 01; 25(6):636-40. PubMed ID: 12223954
    [Abstract] [Full Text] [Related]

  • 34. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.
    Attia S, Khochtali S, Kahloun R, Ammous D, Jelliti B, Ben Yahia S, Zaouali S, Khairallah M.
    Int Ophthalmol; 2016 Feb 01; 36(1):37-44. PubMed ID: 25939987
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Therapeutic window of opportunity in the acute uveitic phase of Vogt-Koyanagi-Harada disease: Prevention of late autoimmune complications by early intervention.
    Abu El-Asrar AM, Al Rashed FA, AlBloushi AF, Tobaigy MF, Gikandi PW, Herbort CP, Opdenakker G.
    Acta Ophthalmol; 2023 Mar 01; 101(2):e236-e245. PubMed ID: 36128841
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.